DUBLIN--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/83a629/pharmaceutical_ind) has
announced the addition of the "Pharmaceutical Industry in Brazil" report to
their offering.
The birth origins of the Pharmaceutical Industry can be traced back to more
humble antecedents than just chemistry labs. The earliest incidents of
recognition of the antiseptic properties of the dyestuffs is around the late
19th century. The invention of penicillin can yet be recognized as a major
milestone for the emergent industry which firmly consolidated its R&D efforts in
the 1950's. Further in the 1960's the patent regulation support gave a further
impetus to the industry in new discoveries and relaxed controls on clinical
development with the booming spend on healthcare as economies boomed globally.
The global presence of the pharmaceutical industry is evident with the roll out
of continent specific R&D programs and drugs which help companies maximize
penetration of markets and garner increased revenues with intercontinental
treatment demand of patients being serviced from often one or two mega research
centers in the continent.
The pharmaceutical industry is under mounting scrutiny because of rapidly
increasing expenditures for drugs worldwide. Drug expenditures are now the
fastest-growing component of health care costs, increasing at the rate of about
15 percent per year. They account for about eight percent of health care
spending, and at their current rate of increase, they will soon surpass spending
for physicians' services and, for many health care organizations, the costs of
hospitalization.
Aruvian's R'search brings you a complete analysis of the Pharmaceutical Industry
in Brazil. The report covers a brief profile of the global pharmaceutical
industry, the TRIPS agreement, offshoring in the pharmaceutical industry,
economic trends in the industry, competition in the industry, and the key
players in the pharmaceutical industry in Brazil - complete with a SWOT analysis
of the leading companies in the market.
Key Topics Covered:
* A. Executive Summary
* B. The Global Pharmaceutical Industry - A Brief Profile
* C. TRIPS and the Global Pharmaceutical Industry
* D. Pharmaceutical Industry in Brazil
* E. Competition in the Industry
* F. Leading Players in the Market
* G. Appendix
* H. Glossary of Terms
Companies Mentioned:
* Novartis AG
* GlaxoSmithKline Plc
* Pfizer Inc
* EMS Sigma Pharma Group
For more information visit
http://www.researchandmarkets.com/research/83a629/pharmaceutical_ind
Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Copyright Business Wire 2009
